Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Hematological Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04349189
What this trial is testing

Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait

Who this might be right for
Sickle Cell DiseaseVenous ThrombosisSickle Cell Trait+2 more
National Heart, Lung, and Blood Institute (NHLBI) 119
Large-scale testing (Phase 3)Study completedNCT00885742
What this trial is testing

Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Who this might be right for
Factor XIII Deficiency
CSL Behring 41
Post-approval studies (Phase 4)Ended earlyNCT00880373
What this trial is testing

Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease - Sickle With Ibuprofen & Morphine

Who this might be right for
Sickle Cell Disease
London North West Healthcare NHS Trust 320
Not applicableStudy completedNCT03233269
What this trial is testing

BEATS 2: Music Therapy in Sickle Cell

Who this might be right for
Sickle Cell Disease
University Hospitals Cleveland Medical Center 50
Not applicableStudy completedNCT02319070
What this trial is testing

2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

Who this might be right for
Hemophilia A
Bayer 72
Testing effectiveness (Phase 2)Study completedNCT03271541
What this trial is testing

Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia

Who this might be right for
Beta-Thalassemia
Hoffmann-La Roche 12
Large-scale testing (Phase 3)WithdrawnNCT06297486
What this trial is testing

Study of a Gene Therapy Treatment for Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc.
Large-scale testing (Phase 3)Study completedNCT03704922
What this trial is testing

Age of Blood in Sickle Cell Transfusion

Who this might be right for
Sickle Cell Disease
University of North Carolina, Chapel Hill 26
Not applicableStudy completedNCT03986229
What this trial is testing

Evaluation of the Effect of Custom Compression Garments on Standing Static Balance in Ehlers Danlos Syndrome

Who this might be right for
Ehlers-Danlos Syndrome
University Hospital, Toulouse 16
Not applicableActive Not RecruitingNCT06511453
What this trial is testing

Acupressure in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Indiana University 59
Testing effectiveness (Phase 2)UnknownNCT03975894
What this trial is testing

TAPS2 Transfusion Antenatally in Pregnant Women With SCD

Who this might be right for
Sickle Cell DiseasePregnancy, High RiskBlood Transfusion Complication
Guy's and St Thomas' NHS Foundation Trust 50
Testing effectiveness (Phase 2)Study completedNCT00462605
What this trial is testing

MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+25 more
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT05833022
What this trial is testing

Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell Centers

Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals 297
Early research (Phase 1)Study completedNCT01228669
What this trial is testing

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 52
Not applicableUnknownNCT01935661
What this trial is testing

A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients.

Who this might be right for
ThalassemiaBrain Function (Measured by ERP Level)
HaEmek Medical Center, Israel 120
Not applicableEnded earlyNCT02698761
What this trial is testing

A Comprehensive Care Plan for Pediatric Patients With Vaso-Occlusive Crises

Who this might be right for
Sickle Cell DiseaseSickle Cell CrisisVaso-Occlusive Crises
Valley Anesthesiology Consultants 3
Not applicableStudy completedNCT07721155
What this trial is testing

Objective Neurocognitive Assessment of Young Children With Sickle Cell Disease by Eye-Tracking

Who this might be right for
Sickle Cell DiseaseSickle CellNeurocognition, Child
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 93
Not applicableStudy completedNCT06043050
What this trial is testing

PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia

Who this might be right for
Neonatal ThrombocytopeniaIntraventricular HemorrhagePlatelet Transfusion
Leiden University Medical Center 1,042
Testing effectiveness (Phase 2)WithdrawnNCT01835288
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Stanford University
Large-scale testing (Phase 3)Ended earlyNCT01405742
What this trial is testing

Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
University of Pittsburgh 4
Next Page